SCHEMBL17532765

SCHEMBL17532765

Cc1cc2c(C)nc3ccccc3c2c(C)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.57
▸ CYP1A2 P05177 3/20 0.53
▸ ALDH1A1 P00352 4/20 0.52
▸ HPGD P15428 3/20 0.52
▸ NUDT1 P36639 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ NCF1 P14598 2/20 0.50
▸ KDM4E B2RXH2 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ OPRM1 P35372 1/20 0.46
▸ OPRD1 P41143 1/20 0.46
▸ UHRF1 Q96T88 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17532762 0.79 GPR3 (0.53) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL21537700 0.76 GPR3 (0.65) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL17532760 0.75 PDPK1 (0.49) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL17532766 0.74 GPR3 (0.57) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL85621 0.73 GPR3 (1.00) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL24164244 0.73 GPR3 (0.61) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL17532763 0.73 GPR3 (0.60) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL17589588 0.72 GPR3 (0.59) GPR3CYP1A2ALDH1A1HPGDNUDT1
SCHEMBL637928 0.71 CYP2A6 (0.50) GPR3CYP1A2ALDH1A1HPGDNUDT1
Hydrochloric Acid SCHEMBL3907848 0.71 GPR3 (0.95) GPR3CYP1A2ALDH1A1HPGDNUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 — — US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 — — US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION AOC2, AZI2, KCNH2 GPR3 3295/4885CYP1A2 978/4885ALDH1A1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback